TATA Health (01255.HK) received additional resumption guidance from the Hong Kong Stock Exchange and will continue to be suspended from trading.

Intelligence Finance APP News, TATA Health (01255.HK) announced that on September 4, 2025, the company received a letter from the Hong Kong Stock Exchange, which included additional guidelines for the resumption of trading of the company's shares on the Hong Kong Stock Exchange (additional resumption guidelines, together with the preliminary resumption guidelines, collectively referred to as "resumption guidelines").